Discovery Life Sciences

Discovery Life Sciences is a global leader in biospecimen analysis, procurement, distribution and scientific services for the pharmaceutical, biotechnology and diagnostics industries. Water Street merged Conversant Bio, Discovery Life Sciences and Folio Bio to create the company in 2018. In 2019, the company added the renowned Genomic Services Laboratory of the HudsonAlpha Institute for Biotechnology and acquired Qualtek Molecular Laboratories. Discovery cemented its position as a global leader in biospecimens through the acquisition of Ukrainian East West Biopharma and Allbio in 2020. In 2021, Discovery Life Sciences added to its successful constellation the unique company "In Vitro ADMET Laboratory (IVAL)", specializing in hepatocyte research, isolation and cryopreservation of hepatocytes, as well as in vitro study of pharmacokinetics, metabolism, toxicity and drug interactions. In the same year, the German company Targos, a state-of-the-art pathomorphological laboratory working in the field of clinical research and providing services for validation and research of biomarkers, digital pathology, joined the company.

In 2022, Discovery Life Sciences also acquired AllCells, an industry leader in the processing of leukopacks, a unique human blood derivative with significant research potential.

Today, Discovery Life Sciences offers a unique and powerful set of innovative solutions, including the resources of one of the world's largest commercial biorepositories and an extensive network of partner clinics, unique HudsonAlpha Discovery sequencing services and bioinformatics laboratories, cell technology laboratory services.